Tomczak, Piotr. 2025. “Cabozantinib in Monotherapy and Combination Therapy for First-Line Renal Cell Carcinoma: Patient Profiles”. OncoReview 15 (1(57), 12-17. https://doi.org/10.24292/01.OR.151220925.